benylan 1,4 mg/ml oral opløsning
mcneil denmark aps - diphenhydraminhydrochlorid - oral opløsning - 1,4 mg/ml
benylan 2,8 mg/ml oral opløsning
mcneil denmark aps - diphenhydraminhydrochlorid - oral opløsning - 2,8 mg/ml
coldycof 1,4 mg/ml oral opløsning
orifarm generics a/s - diphenhydraminhydrochlorid - oral opløsning - 1,4 mg/ml
coldycof 2,8 mg/ml oral opløsning
orifarm generics a/s - diphenhydraminhydrochlorid - oral opløsning - 2,8 mg/ml
wakix
bioprojet pharma - pitolisant - narkolepsi - andre narkotika stoffer - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
bloxazoc 100 mg depottabletter
krka d.d. novo mesto - metoprololsuccinat - depottabletter - 100 mg
bloxazoc 200 mg depottabletter
krka d.d. novo mesto - metoprololsuccinat - depottabletter - 200 mg
bloxazoc 25 mg depottabletter
krka d.d. novo mesto - metoprololsuccinat - depottabletter - 25 mg
bloxazoc 50 mg depottabletter
krka d.d. novo mesto - metoprololsuccinat - depottabletter - 50 mg
ozawade
bioprojet pharma - pitolisant - sleep apnea, obstructive - andre narkotika stoffer - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).